Managing abnormal blood lipids: A collaborative approach

Barbara Fletcher, Kathy Berra, Phil Ades, Lynne T. Braun, Lora E. Burke, J. Larry Durstine, Joan M. Fair, Gerald F. Fletcher, David Goff, Laura L. Hayman, William R. Hiatt, Nancy Houston Miller, Ronald Krauss, Penny Kris-Etherton, Neil Stone, Janet Wilterdink, Mary Winston

Research output: Contribution to journalReview articlepeer-review

177 Scopus citations


Current data and guidelines recommend treating abnormal blood lipids (ABL) to goal. This is a complex process and requires involvement from various healthcare professionals with a wide range of expertise. The model of a multidisciplinary case management approach for patients with ABL is well documented and described. This collaborative approach encompasses primary and secondary prevention across the lifespan, incorporates nutritional and exercise management as a significant component, defines the importance and indications for pharmacological therapy, and emphasizes the importance of adherence. Use of this collaborative approach for the treatment of ABL ultimately will improve cardiovascular and cerebrovascular morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)3184-3209
Number of pages26
Issue number20
StatePublished - Nov 2005


  • AHA Scientific Statements
  • Cholesterol
  • Lipids
  • Prevention
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Managing abnormal blood lipids: A collaborative approach'. Together they form a unique fingerprint.

Cite this